Table 1. Overview of LRP6 variants identified with MIP screen in OFC and TA patients vs. controls.
Total cases w. variant (n=1139) | TA cases w. variant (n=67) | OFC cases w. variant (n=1072) | Controls w. variant (n=706) | |
---|---|---|---|---|
Rare (<0.1%) coding & SS$ variants | 30 | 8 | 22 | 16 |
Of which synonymous | 3 | 1 | 2 | 3 |
Of which non-synonymous | 27 | 7a | 20b | 13a,b |
Unique/private variants | 13 | 5 | 8 | 5 |
Of which synonymous | 1 | 0 | 1 | 2 |
Of which non-synonymous | 12 | 5c | 7d | 3c,d |
Of which CADD PHRED >20 | 7 | 4e | 3f | 1e,f |
Splice site canonical dinucleotide; CADD PHRED-like score (Kircher et al. 2014, Nature Genetics).
7 rare, non-synonymous variants in LRP6 in 67 cases with OD were highly significant when compared to the variant load in 706 controls (Fisher's exact test after Bonferroni correction P = 0.0056022); while 20 rare, non-synonymous variants in LRP6 in 1072 cases with OFC does not show significance when compared to the variant load in 706 controls.
5 unique, non-synonymous variants in LRP6 in 67 cases with OD were highly significant when compared to 3 such variants in 706 controls (Fisher's exact test after Bonferroni correction P = 0.0012354); while 7 unique, non-synonymous variants in LRP6 in 1072 cases with OFC does not show significance when compared to the variant load in 706 controls.
4 unique, predicted damaging variants in LRP6 in 67 cases with OD were highly significant when compared to 1 such variant in 706 controls (Fisher's exact test after Bonferroni correction P = 0.001515); while 7 unique, non-synonymous variants in LRP6 in 1073 cases with OFC does not show significance when compared to the variant load in 706 controls.